机构：[1]Department of Ophthalmology, Peking University People's Hospital, Xizhimen South Street No. 11, Beijing, 100044, China.[2]Eye Diseases and Optometry Institute, Beijing, China.[3]Beijing Key Laboratory of Diagnosis and Therapy of Retina and Choroid Diseases, Beijing, China.[4]College of Optometry, Peking University Health Science Center, Beijing, China
To evaluate the association between single nucleotide polymorphisms (SNPs) in the complement factor H (CFH) gene and response to PDT in patients with CSC.103 eyes from 93 patients with CSC were enrolled from Department of Ophthalmology of the People's Hospital Peking University. Genotyping for selected SNPs in the CFH gene was performed, and multivariate linear analysis was used to identify factors influencing PDT treatment outcomes. Genetics associations between SNPs in the CFH gene and response to PDT in patients with CSC were analyzed.None of the seven SNPs examined in this study (rs800292, rs1061170, rs3753394, rs3753396, rs2284664, rs1329428, and rs1065489) showed significant associations with 1-month outcomes after PDT in patients with CSC (P > 0.05). Baseline BCVA changed at 1 month after PDT (P < 0.001), and baseline retinal thickness was associated with changes in retinal thickness at 1 month after PDT (P < 0.001). Age was significantly associated with resolution of SRF at 1 month after PDT (P = 0.004).There were no significant associations between SNPs in the CFH gene and 1-month outcomes after PDT in patients with CSC. However, baseline BCVA, baseline retinal thickness, and age were significantly associated with response to PDT in patients with CSC. Larger studies with more power are necessary to further determine whether an association exists between SNPs in the CFH gene and PDT in patients with CSC.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类|4 区医学
小类|4 区眼科学
最新[2025]版：
大类|4 区医学
小类|4 区眼科学
第一作者：
第一作者机构：[1]Department of Ophthalmology, Peking University People's Hospital, Xizhimen South Street No. 11, Beijing, 100044, China.[2]Eye Diseases and Optometry Institute, Beijing, China.[3]Beijing Key Laboratory of Diagnosis and Therapy of Retina and Choroid Diseases, Beijing, China.[4]College of Optometry, Peking University Health Science Center, Beijing, China
共同第一作者：
通讯作者：
通讯机构：[1]Department of Ophthalmology, Peking University People's Hospital, Xizhimen South Street No. 11, Beijing, 100044, China.[2]Eye Diseases and Optometry Institute, Beijing, China.[3]Beijing Key Laboratory of Diagnosis and Therapy of Retina and Choroid Diseases, Beijing, China.[4]College of Optometry, Peking University Health Science Center, Beijing, China
推荐引用方式(GB/T 7714)：
Linghu Dandan,Xu Hui,Liang Zhiqiao,et al.Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy.[J].International ophthalmology.2020,40(4):951-956.doi:10.1007/s10792-019-01261-y.
APA：
Linghu Dandan,Xu Hui,Liang Zhiqiao,Gao Tingting,Lin Zhaojun...&Zhao Mingwei.(2020).Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy..International ophthalmology,40,(4)
MLA：
Linghu Dandan,et al."Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy.".International ophthalmology 40..4(2020):951-956
